Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antiasthmatic/zánět

Odkaz je uložen do schránky
Strana 1 z 113 Výsledek

Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The invention relates to the potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs. Despite the fact that more refined drugs are available and that asthma care is better overall, nevertheless the mortality and morbidity of

Potentiation of the anti-reactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The invention relates to the potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs. Despite the fact that more refined drugs are available and that asthma care is better overall, nevertheless the mortality and morbidity of
BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to 1-[(3- or 4-benzoylphenyl)-lower-alkyl]-[(CH.sub.2).sub.n --N.dbd.B]-substituted-piperidines and analogs thereof, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents;
TECHNICAL FIELD The invention relates to the preparation and use of novel derivatives of indazol-3-ol as medicaments having anti-asthmatic, anti-allergic, anti-inflammatory, immuno-nodulating and neuroprotective properties. PRIOR ART Cyclosporin A (CsA) or FK 506 are immunosuppressant natural

Muscle-strengthening drugs and anti-inflammatory drugs

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD The present invention relates to a novel agent or composition for use as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction (human stroke

Amorphous (quinolin-2-ylmethoxy)indole compounds useful for treating inflammatory diseases

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION EP 419,049, Prasit et al., Mar. 27, 1991, describes a series of quinolin-2-ylmethoxy indoles useful as inhibitors of leukotriene biosynthesis. Examples 1 and 1A therein teach the synthesis of 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-

Use of 3-(arylmethyleneamino)-1-aryl-2-pyrazolines in the prophylaxis and treatment of inflammation, pain, pyresis, and asthma

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
This invention relates to heterocyclic compounds and their preparation and to the use of such compounds of pharmaceutical formulations thereof in medicine in a mammal, including man, as e.g. anti-inflammatory or anti-allergic agents or as agents in the prevention of tissue rejection. Accordingly,
TECHNICAL FIELD The present invention relates to a composition comprising an extract of Tiarella polyphylla and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. BACKGROUND ART Asthma has been regarded as a complex syndrome occurring in the
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a 371 of PCT/KR2006/002092 filed on May 30, 2006, which claims the benefit of Korean Patent Application Nos. 10-2005-0045755 filed on May 30, 2005, 10-2005-0045756 filed on May 30, 2005, 10-2006-0048104 filed on May 29, 2006 and
TECHNICAL FIELD The present invention relates to a composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. BACKGROUND ART Asthma has been regarded as a complex syndrome
TECHNICAL FIELD The present invention relates to a composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. BACKGROUND ART Asthma has been regarded as a complex syndrome

Metabolically inert anti-inflammatory and anti-tumor antifolates

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION This invention relates to folic acid antagonists that are metabolically inert exhibiting a high level of anti-inflammatory and anti-tumor activity. Metabolically inert classical antifolates are new and therefore they exhibit unexpected biological properties such as those recited

[3H,7H]thiazolo[3,4-a]pyridines with antiasthmatic and antiinflammatory actions on the respiratory tract

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to [3H, 7H]thiazolo[3,4-a]-pyridines, a method for preparing them and pharmaceutical compositions which contain them. More precisely the invention relates to compounds of formula (I) ##STR2## in which: R is (C.sub.1 -C.sub.4) alkyl; R.sub.1 is a cyano, free or salified

N-hydroxyurea derivative and pharmaceutical composition containing the same

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD The present invention relates to novel N-hydroxyurea derivative having a lipoxygenase inhibitory activity and a thromboxane synthase inhibitory activity and pharmaceutical composition containing the same. BACKGROUND ART In recent years, the role of chemical mediators in asthma and

Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION The leukotrienes and their biological activities, especially their role in various disease states, have been extensively studied. Their properties are described in the book Leukotrienes and Lipoxygenases, Ed., J. Rokach, Elsevier, N.Y., 1989. Inhibitors of the
Připojte se k naší
facebookové stránce

Nejúplnější databáze léčivých bylin podložená vědou

  • Funguje v 55 jazycích
  • Bylinné léky podporované vědou
  • Rozpoznávání bylin podle obrázku
  • Interaktivní mapa GPS - označte byliny na místě (již brzy)
  • Přečtěte si vědecké publikace související s vaším hledáním
  • Hledejte léčivé byliny podle jejich účinků
  • Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty

Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu

Google Play badgeApp Store badge